Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 96,071 shares of the company’s stock after acquiring an additional 1,600 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Cardinal Health were worth $11,362,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Assenagon Asset Management S.A. lifted its position in Cardinal Health by 5.2% during the third quarter. Assenagon Asset Management S.A. now owns 10,930 shares of the company’s stock worth $1,208,000 after buying an additional 545 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in Cardinal Health by 93.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 46,065 shares of the company’s stock worth $5,091,000 after buying an additional 22,267 shares during the period. Reston Wealth Management LLC purchased a new position in Cardinal Health during the third quarter worth about $67,000. Farther Finance Advisors LLC lifted its position in Cardinal Health by 3.6% during the third quarter. Farther Finance Advisors LLC now owns 7,435 shares of the company’s stock worth $822,000 after buying an additional 260 shares during the period. Finally, Janney Montgomery Scott LLC lifted its position in Cardinal Health by 1.8% during the third quarter. Janney Montgomery Scott LLC now owns 239,102 shares of the company’s stock worth $26,426,000 after buying an additional 4,209 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH stock opened at $129.71 on Friday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The firm has a market cap of $31.33 billion, a P/E ratio of 24.20, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The stock has a 50-day simple moving average of $124.74 and a 200-day simple moving average of $118.06.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.56%. Cardinal Health’s dividend payout ratio is presently 37.69%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Morgan Stanley increased their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. Argus set a $148.00 price objective on Cardinal Health in a report on Tuesday, February 4th. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. JPMorgan Chase & Co. raised their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, Citigroup raised their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.